CareDx Q3 revenue $100.1M (+21% YoY), turns to GAAP net income $1.7M; raises FY guidance

CareDx, Inc.

2025-Q3 EPS reported -$0.32 revenue$271,419,000

Revenue $100.1M, up 21% YoY; testing services volume ~50,300 (+13% YoY).
GAAP net income $1.7M vs loss $10.6M in Q3 2024; adjusted EBITDA $15.3M vs $6.9M.
Raised FY 2025 revenue guidance to $372M-$376M (from $367M-$373M); raised adj. EBITDA guidance to $35M-$39M.
Cash $194.2M, no debt; repurchased $25.6M shares during quarter.
Appointed new CMO Jeff Teuteberg, MD and board member Suresh Gunasekaran.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.